Insulin Syringes are the most typical precision drug delivery product in the disposable syringe system, primarily used for subcutaneous insulin injection. Compared to conventional syringes, this category of products has a more focused purpose, and its design logic emphasizes small volume, clear unit graduations, short and thin needles, and single-use attributes. The FDA's consumer guidelines explicitly list insulin needles and syringes as one of the common insulin delivery devices, widely used in both clinical and home settings. At the technical standards level, ISO 8537, recognized by the FDA, specifically addresses requirements for "sterile disposable syringes (with or without needles) for insulin injection," indicating that this type of product has developed a mature and independent product standard system.
Structurally, Insulin Syringes typically employ a smaller volume range to facilitate more precise dosage management. The most common specifications for mainstream products in this category are 0.3 mL, 0.5 mL, and 1 mL, corresponding to 30, 50, and 100 units in the U-100 system. Most products employ a fixed needle structure, with needle sizes typically ranging from 27G to 31G, and shorter needle lengths such as 8 mm and 12.7 mm are predominant. This is to better suit subcutaneous injections and improve comfort and controllability for daily use. This typical configuration can be seen on Nipro's official product page and BD-related sales channel pages: 0.3/0.5/1 mL, fixed needle, 27–31G, 8 mm or shorter needle length, which has become a very common product combination in the international market.
The core value of this category lies in "precision, stability, and high-frequency daily use." Insulin administration is not a one-time, low-frequency medical procedure, but rather a long-term, regular, and repetitive chronic disease management behavior. Therefore, buyers focus more on the following aspects of the product: clear scale markings, easy dosage reading, sufficiently short and fine needles, smooth injection, clear single-use dosage, and packaging suitable for pharmacy and home distribution. The FDA emphasizes in its insulin guidelines that insulin injections must be performed subcutaneously, and needles and syringes should not be shared. The Cleveland Clinic also points out that subcutaneous injections typically use short, fine needles, and the commonly used injection volume is small, around 1 mL. These characteristics collectively determine that insulin injectors must build their product value around "small dose, subcutaneous, single-use, and easy-to-read scale."
In this niche market, another crucial feature of Insulin Syringes is that their compatibility with the "concentration and calibration system" is more critical than that of ordinary syringes. Mayo Clinic emphasizes on multiple insulin medication pages that dose and concentration are not the same concept, and that the dosage and concentration used must be repeatedly confirmed to be consistent. The FDA, in its announcement regarding the U-500 dedicated syringe, also points out that there were significant conversion risks when patients used U-100 syringes or volumetric syringes to convert U-500 insulin dosages. Therefore, the introduction of the dedicated U-500 syringe aims to reduce dosing errors. In other words, insulin syringes, in commercial presentations, are not merely "small-sized syringes," but should be defined as specialized products closely related to insulin concentration, unit marking, fixed needles, and dosing accuracy.
From the perspective of independent website category building, "Insulin Syringes" is suitable as a separate secondary category because it has a very clear user search intent and product boundaries. Customers entering this page are typically not generally looking for syringes, but rather for highly specific products such as insulin syringes, disposable insulin syringes, U-100 insulin syringes, and fixed needle insulin syringes. Compared to the general category of disposable syringes, the insulin syringe page allows for more targeted content creation based on volume, unit graduations, needle gauge, needle length, needle fixing structure, ease of home use, and long-term chronic disease care needs. It is also better suited for expanding to finer specification levels such as 0.3 mL/0.5 mL/1 mL, 29G/30G/31G, and 8 mm/12.7 mm. For medical device distributors, pharmacy channels, chronic disease care product customers, and the overseas diabetes management market, this category possesses clear professional attributes, stable repurchase logic, and continuous procurement value.
Absorbable suture material is one of those quiet workhorses of surgery. It holds tissue together long enough for healing to begin, then disappears wi...
READ MOREChoosing between a No. 11 and a No. 15 scalpel blade is less about which blade is “better” and more about matching blade geometry to the cut you need...
READ MOREA B12 injection carries a very small volume of solution, often half a millilitre or less, yet the needle that delivers it decides how comfortable the...
READ MOREVitamin B12 replacement looks simple on paper: a small-volume injection, a schedule, and a follow-up plan. In practice, the phrase “b12 dosing im” ra...
READ MOREIndustry Knowledge
Jiangsu Zhiyu Medical Instrument Co., Ltd. is a China-based Insulin Syringes manufacturer supplying sterile single-use insulin syringes for subcutaneous insulin delivery in clinical, pharmacy and home-care channels. Our range covers 0.3 mL, 0.5 mL and 1 mL U-100 configurations with fixed 27G–31G needles, supported by OEM/ODM packaging, specification extension and project-based coordination from sampling to volume production.
Insulin syringes sit inside our broader Medical Consumables programme, alongside Disposable Syringes, hypodermic needles, butterfly needles and infusion sets. The category is defined by small-volume precision dosing rather than general injection use: unit graduations, fixed-needle construction and short, fine needles are the design priorities.
We manufacture this family for distributors, pharmacy chains, chronic-care programmes and private-label brand owners. Because insulin administration is a repeated daily behaviour, our production planning treats scale consistency, clear scale printing and packaging suitable for pharmacy and home distribution as core requirements rather than optional features.
The mainstream commercial combination is a 0.3/0.5/1 mL barrel with a fixed needle, 27G–31G gauge and short needle length such as 8 mm or 12.7 mm. Our proposal is built around the working concentration, the target patient or channel and the required unit scale.
| Barrel Volume | U-100 Unit Scale | Typical Needle Gauge | Typical Needle Length | Application Fit |
|---|---|---|---|---|
| 0.3 mL | 30 units | 29G–31G | 8 mm | Low-dose regimens, paediatric and fine titration |
| 0.5 mL | 50 units | 28G–31G | 8 mm / 12.7 mm | General adult subcutaneous dosing |
| 1 mL | 100 units | 27G–30G | 12.7 mm | Higher-volume regimens, clinical and hospital supply |
| Concentration-specific | Matched to U-40 / U-100 / U-500 | 27G–31G | 8 mm / 12.7 mm | Markets where scale and concentration must be locked together |
Scale and concentration must be treated as one specification. A U-100 barrel marked in units is not interchangeable with a volumetric syringe when a different concentration is dispensed, so we confirm the concentration system before printing plates or moulds are committed.
Zhiyu operates a collaborative production system covering injection moulding, assembly, testing and packaging on related product lines, with automated equipment, online inspection and standardised quality control supporting batch consistency. Our insulin syringe line is produced under cleanroom conditions with in-line inspection and retained samples managed through shelf life.
For applicable product lines we hold ISO 13485:2016 certification, EU MDR quality management system certification covering insulin syringes among other products, FDA establishment registration and device listing, and FDA 510(k) clearance for specified sterile syringe and hypodermic needle products. Regulatory scope differs by product and target market, so the applicable documents are confirmed against the specific item and destination before a project is released.
Beyond standard supply, we support product matching and assortment planning, specification confirmation and extension, packaging adaptation and development, private-label support, structural optimisation and, for suitable projects, mould development and customised product development. This allows a distributor or brand owner to move from a product concept through sampling and validation into volume production without changing manufacturing partner.
Packaging can be planned as neutral bulk, colour box, blister or PE bag formats with multilingual label design, matched to pharmacy, hospital or home-care distribution. The Insulin Syringes range is also available alongside related single-use items such as Medical Needles & IV Products for consolidated shipments.
To prepare a configuration and quotation we work from the following project inputs. Early clarity on concentration, scale and packaging shortens the path from evaluation to sampling.
Insulin syringes are supplied sterile and ready for use, so the practical requirements are storage, handling and traceability rather than on-site installation. We recommend storage in a dry, protected area within the labelled temperature range, with stock rotated by lot and packaging kept intact until use.
For repeat programmes we maintain inspection records, quality reports and retained samples, and we coordinate spare or replacement supply through the same project channel. Documentation and training material can be prepared around the agreed specification so that receiving, storage and dispensing staff work from one reference.
We produce 0.3 mL, 0.5 mL and 1 mL barrels corresponding to 30, 50 and 100 units in the U-100 system, with fixed needles in the 27G–31G range and common lengths of 8 mm and 12.7 mm. Other combinations are evaluated as specification extensions.
Yes. Scale and concentration are confirmed together at the start of the project so that the printed unit markings match the concentration the product will be used with. This is particularly relevant where U-40, U-100 or U-500 systems coexist in one market.
We support OEM/ODM cooperation covering packaging adaptation, specification extension, private-label support, structural optimisation and, for applicable projects, mould development and customised product development, with coordination from sampling through to volume production.
For applicable product lines we hold ISO 13485:2016 certification, EU MDR quality management system certification, FDA establishment registration and device listing, and FDA 510(k) clearance for specified sterile syringe and hypodermic needle products. The applicable documents are confirmed against the specific product and target market.
Production runs under cleanroom conditions with automated equipment, in-line inspection and standardised quality control procedures. Incoming material, in-process and final product inspection are recorded, and retained samples are kept through shelf life for traceability.
Barrel volume, unit scale, needle gauge and length, packaging format, target market, estimated quantity and whether private label is required. Drawings, photos or reference samples help us confirm the specification more precisely before sampling.